Article Information
History
- July 6, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Kensuke Ikenaka1,*,
- Yasuhiro Maeda2,
- Yuji Hotta3,
- Seiichi Nagano1,
- Keita Kakuda1,
- Harutsugu Tatebe4,5,
- Naoki Atsuta6,7,
- Daisuke Ito6,
- Cesar Aguirre1,
- Yasuyoshi Kimura1,
- Kousuke Baba1,
- Masahisa Katsuno6,
- Takahiko Tokuda4,5,
- Kazunori Kimura3,
- Gen Sobue8,9 and
- Hideki Mochizuki1
- 1Department of Neurology, Osaka University Graduate School of Medicine, Suita, Japan
- 2Center for Joint Research Facilities Support, Fujita Health University, Toyoake, Japan
- 3Department of Hospital Pharmacy, Nagoya City University Graduate School of Pharmaceutical Sciences, Nagoya, Japan
- 4T & T Brothers Corporation, Chiba, Japan
- 5National Institutes for Quantum and Radiological Science and Technology (QST), Chiba, Japan
- 6Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan
- 7Department of Neurology, Aichi Medical University School of Medicine, Nagakute, Japan
- 8Research Division of Dementia and Neurodegenerative Disease, Nagoya University Graduate School of Medicine, Nagoya, Japan
- 9Aichi Medical University, Nagakute, Japan
- ↵*Corresponding Author:
Kensuke Ikenaka, Department of Neurology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita 565-0871, Japan, Phone: +81-6-6879-3571, E-mail: ikenaka{at}neurol.med.osaka-u.ac.jp
Posted July 06, 2021.
Serum asymmetric dimethyl arginine level correlates with the progression and prognosis of amyotrophic lateral sclerosis
